medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2017, Number 12

<< Back Next >>

Ginecol Obstet Mex 2017; 85 (12)

Hypomagnesemia during pregnancy: Risk factor for severe preeclampsia?

Loustaunau-Soto LR, Ramos-Martínez MA, Favela-Heredia CE, Garzón-López O, Coronel-Zamudio A, Murillo-Llanes J

Language: Spanish
References: 18
Page: 819-824
PDF size: 342.51 Kb.


ABSTRACT

Objetive: To demonstrate that hypomagnesemia is a risk factor for severe preeclampsia.
Materials and Methods: A case-control study conducted in patients treated at the Hospital de la Mujer between the months of January 2015 and January 2016. The study group included patients with severe preeclampsia and healthy pregnant controls with determination of concentrations of magnesium serum.
Results: 200 patients were studied; the average age of the hypertensive pregnant women was 24.6 years, and 23.5 years of the normotensive women. The difference between the two was 1.1 years (p › 0.05). The median in weeks of gestation of hypertensive women was 37 and 39 for healthy women, respectively; the difference was 2 (p = 0.0001). The median magnesium of the hypertensive women was 1.7 mg/dL, and in the non-hypertensive 1.8 mg/dL, (p = 0.0053); RM: 1.72 IC95%: 1.0- 3.13; p = 0.005.
Conclusions: in this study group, it was shown that hypomagnesemia is a risk factor for severe preeclampsia.


REFERENCES

  1. Marín-Iranzo R, Gorostidi-Pérez M, Álvarez-Navascués R. Hipertensión arterial y embarazo. NefroPlus 2011;4(2):21-30.

  2. Kokko JP, Tannen RL, ed. Fluids and electrolytes. 3rd ed. Philadelphia: WB Saunders, 1996;63-109.

  3. Spätling L. Magnesium in obstetrics and gynecology. Gynakol Geburtshilfliche-Rundsch l993;33(2):85-91.

  4. Zarcone R, Cardone G, Bellini P. Role of magnesium in pregnancy. Panminerva-Med l994;36(4):168-70.

  5. Bruno Sontia, Rhian M. Touyz. Role of magnesium in hypertension. Archives of Biochemistry and Biophysics 2007;458(1):33-39.

  6. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013 Nov;122(5):1122-31.

  7. Rondón Berríos H. Hipomagnesemia. An Fac Med Lima 2006;67(1):38-58.

  8. Villanueva LA, Figueroa A, Villanueva S. Concentraciones séricas de electrolitos en mujeres con preeclampsia severa. Rev Hosp Gral Dr. Manuel Gea González, Octubre- Diciembre 2000; 3(4): 166-169.

  9. Yamamoto-Seto G, Herrera-Añazco P, Hurtado-Aréstegui A, Rojas-Rivera J, León-Vega J L. Estudio comparativo de los niveles séricos de magnesio iónico en mujeres no gestantes, gestantes normales y gestantes con preeclampsia. Rev Soc Peru Med Interna 2008; 21 (1):7-10.

  10. Soto Tarazona A, Hurtado Arestegui A. Estudio comparativo del nivel sérico, urinario, y excreción fraccionada de magnesio en gestantes con preeclampsia y sin preeclampsia. Bol Soc Peru Med Interna 1998; 11(4):177-81.

  11. Adam B, Malatyaliolu E, Alvur M, Talu C. Magnesium, zinc and iron levels in pre-eclampsia. J Matern Fetal Med 2001;10:246-50.

  12. Kisters K, Barenbrock M, Louwen F, et al. Membrane, intracellular and plasma magnesium and calcium concentrations in preeclampsia. Am J Hypertens 2000; 13:765-9.

  13. Ruiz A. Comparación del nivel sérico de magnesio vs. parámetros clínicos en el manejo de preeclampsia severa y eclampsia. Tesis de Laboratorio Clínico. Eselac-PNP, Lima, 2005.

  14. Enaruna NO, Ande A, Okpere EE. Clinical significance of low serum magnesium in pregnant women attending the University of Benin Teaching Hospital. Niger J Clin Pract. 2013 Oct-Dec;16(4):448-53.

  15. Villanueva LA, Figueroa A, Villanueva S. Concentraciones séricas de electrolitos en mujeres con preeclampsia severa. Rev Hosp Gral Dr. M Gea González 2000;3(4):166-169.

  16. Ephraim RKD, Osakunor DNM, Denkyira SW, Eshun H, Amoah S, Anto EO. Serum calcium and magnesium levels in women presenting with pre-eclampsia and pregnancyinduced hypertension: a case–control study in the Cape Coast metropolis, Ghana. BMC Pregnancy and Childbirth. 2014;14:390.

  17. Chelli D, Hamdi A, Saoudi S, Jenayah AA, Zagre A, Jguerim H, Bedis C, Sfar E. Clinical Assessment of Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio for the Diagnostic and the Prognosis of Preeclampsia in the Second Trimester. Clin Lab. 2016 Oct 1;62(10):1927-1932.

  18. Stepan, H., Herraiz, I., Schlembach, D., Verlohren, S., Brennecke, S., Chantraine, et al. (2015). Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of preeclampsia in singleton pregnancy: implications for clinical practice. Ultrasound in Obstetrics & Gynecology, 45(3), 241–246.




2020     |     www.medigraphic.com